AI brief of an SEC Form 8-K · Intuitive Surgical (ISRG)

Intuitive Surgical board lifts buyback authorization to $5.0 billion; shareholders approve plan

Neutral Impact 3 of 5 shareholder Written later

Intuitive Surgical's board raised the authorized amount under its stock repurchase program to an aggregate $5.0 billion, including amounts remaining under prior authorization. At its April 30, 2026 annual meeting, stockholders elected all ten board nominees, approved the advisory pay vote, ratified PricewaterhouseCoopers LLP, and approved an amended 2010 incentive plan that adds 5,000,000 shares to the reserve.

Key points

  • Repurchase program authorization raised to an aggregate $5.0 billion, including amounts remaining under previous authorization, approved April 30, 2026
  • Amended 2010 Incentive Award Plan increases reserved shares from 120,350,000 to 125,350,000 and extends the term to January 29, 2036
  • All ten director nominees elected to serve until the 2027 annual meeting; Proposal No. 2 pay vote approved on an advisory basis
  • Company says repurchases may be suspended at any time and will be funded through cash, cash equivalents, and investments

The filing

CompanyIntuitive Surgical (ISRG)
Form8-K, current report
Filed with the SECMay 4, 2026, 4:05 PM ET
Accession number0001035267-26-000035

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 2:16 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 04, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.